RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Kuhnt-Junius degeneration
Accession: DOID:10873
browse the term
Definition: A form of RETINAL DEGENERATION in which abnormal CHOROIDAL NEOVASCULARIZATION occurs under the RETINA and MACULA LUTEA, causing bleeding and leaking of fluid. This leads to bulging and or lifting of the macula and the distortion or destruction of central vision.
Synonyms: exact_synonym: Exudative Macular Degeneration; Exudative senile macular degeneration of retina; Neovascular Age-Related Macular Degeneration; Senile macular degeneration, wet; Wet Macular Degeneration; Wet Macular Degenerations; Wet senile macular retinal degeneration; exudative age-related macular degeneration
primary_id: MESH:D057135 ; RDO:0007784
xref: EFO:0004683 ; ICD10CM:H35.32 ; ICD9CM:362.52
For additional species annotation, visit the
Alliance of Genome Resources .
G
Anxa5
annexin A5
ISO
mRNA:increased expression:white blood cell:
RGD
PMID:19684010
RGD:6478714
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
G
Apoe
apolipoprotein E
susceptibility
ISO
DNA:polymorphism:exon:
RGD
PMID:9512153 PMID:16079201
RGD:7495762 , RGD:7775015
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
C3
complement C3
ISO
DNA:SNP: :rs2241394 (human)
RGD
PMID:22174912
RGD:7401249
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Ccl2
C-C motif chemokine ligand 2
severity
ISO
protein:increased expression:aqueous humor of eyeball (human)
RGD
PMID:20937997
RGD:8548855
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccr2
C-C motif chemokine receptor 2
ISO
protein:increased expression:monocyte:
RGD
PMID:22789920
RGD:8661669
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Cfi
complement factor I
ISO
DNA:SNPs: :rs10033900, rs13117504 (human)
RGD
PMID:23900096
RGD:8662315
NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
G
Crp
C-reactive protein
treatment
ISO
DNA:SNPs: :rs2808635,rs876538(human)
RGD
PMID:19692124 PMID:17400294
RGD:9491756 , RGD:9491775
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Eln
elastin
no_association
ISO
DNA:SNPintron: rs2301995(human)
RGD
PMID:22065928 PMID:18326737
RGD:7387224 , RGD:9585729
NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928
G
Fgd6
FYVE, RhoGEF and PH domain containing 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27089177
NCBI chr 7:28,597,609...28,712,908
Ensembl chr 7:28,597,609...28,712,456
G
Flt1
Fms related receptor tyrosine kinase 1
susceptibility treatment
ISO
DNA:SNP::rs9943922, rs9508034, rs2281827, rs7324510, rs9513115 (human) protein:increased expression:vitreous:
RGD
PMID:24812550 PMID:20609706 PMID:22868384
RGD:10402108 , RGD:10402116 , RGD:10402118
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
DNA:deletion, haplotype:: (human)
RGD
PMID:28221473
RGD:12792224
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
susceptibility
ISO
DNA:polymorphism::(rs1695)(human) DNA:deletion, haplotype:: (human)
RGD
PMID:22487578 PMID:28221473
RGD:8547932 , RGD:12792224
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gstt1
glutathione S-transferase theta 1
susceptibility
ISO
DNA:deletion, haplotype:: (human)
RGD
PMID:28221473
RGD:12792224
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Htra1
HtrA serine peptidase 1
susceptibility
ISO
DNA:snp:promoter:g.-625G>A (rs11200638) (human) DNA:silent mutations:exon:g.+102C>T, g.+108G>T/C (rs1049331, rs2293870) (human)
RGD
PMID:22800422 PMID:18164066
RGD:7387322 , RGD:7394724
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
G
Igf1
insulin-like growth factor 1
ISO
protein:increased expression:aqueous humor of eyeball: mRNA,protein:increased expression:endothelial cell:
RGD
PMID:24106111 PMID:12714661
RGD:10045867 , RGD:10045893
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
ISO
mRNA,protein:increased expression:endothelial cell:
RGD
PMID:12714661
RGD:10045893
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Igfbp2
insulin-like growth factor binding protein 2
ISO
protein:increased expression:aqueous humor of eyeball:
RGD
PMID:24106111
RGD:10045867
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
G
Il6
interleukin 6
ISO
protein:increased expression:aqueous humor:
RGD
PMID:22490043
RGD:7829793
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Kdr
kinase insert domain receptor
susceptibility
ISO
DNA:SNP: :rs2071559(human)
RGD
PMID:22919317
RGD:8549752
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Loxl1
lysyl oxidase-like 1
ISO
DNA:SNP:exon:p.R141L (human)
RGD
PMID:21236409
RGD:7387334
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
G
Mapk8
mitogen-activated protein kinase 8
ISO
RGD
PMID:23341606
RGD:10412675
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mdm1
Mdm1 nuclear protein
ISO
DNA, mRNA:nonsense mutation, decreased expression:retina
RGD
PMID:18805803
RGD:10412062
NCBI chr 7:53,729,603...53,766,034
Ensembl chr 7:53,729,610...53,766,034
G
Mthfr
methylenetetrahydrofolate reductase
susceptibility
ISO
DNA:SNP:cds:rs1801133(human)
RGD
PMID:22065928
RGD:7387224
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Nos3
nitric oxide synthase 3
susceptibility
ISO
DNA:snp:cds:c.894G>T (rs1799983) (human)
RGD
PMID:23276910
RGD:7771558
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Pdgfb
platelet derived growth factor subunit B
ISO
protein:increased expression:plasma:
RGD
PMID:24334449
RGD:10449444
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfrb
platelet derived growth factor receptor beta
ISO
RGD
PMID:22773904
RGD:10053644
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Pon1
paraoxonase 1
susceptibility
ISO
protein:decreased activity:serum (human) DNA:missense mutations:cds:p.L55M, p.Q192R (human)
RGD
PMID:19155603 PMID:20042177
RGD:8547556 , RGD:8547668
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Sod2
superoxide dismutase 2
susceptibility
ISO
DNA:polymorphism:cds:p.V16A(rs4880)(human)
RGD
PMID:18573360
RGD:8158102
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Tlr2
toll-like receptor 2
ISO
mRNA:increased expression:peripheral blood mononuclear cell:
RGD
PMID:23946637
RGD:8552827
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr3
toll-like receptor 3
ISO
mRNA:increased expression:peripheral blood mononuclear cell:
RGD
PMID:23946637
RGD:8552827
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
G
Vegfa
vascular endothelial growth factor A
treatment
ISO
DNA:SNP: :rs943080(human) DNA:SNP: :rs3025000(human)
RGD
PMID:23745581 PMID:23149126
RGD:7483607 , RGD:7483627
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Il6
interleukin 6
ISO
RGD
PMID:24790857
RGD:10402815
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
treatment
ISO
RGD
PMID:24790857
RGD:10402815
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all